Symphony Ltd
₹507.35
+5.75 (1.15%)
Fri, 06 Nov 2026, 02:05 pm
Symphony News
Symphony sells Ahmedabad land for ₹27 crore
Symphony Ltd finalizes sale of vacant land in Ahmedabad for ₹27 crore, exceeding book value of ₹5.68 crore. Sale deed expected November 6, 2026.
30 Oct 2026
companies
Symphony Q2 profit rises 26% to ₹24 crore
Symphony reported a 26% YoY jump in net profit to ₹24 crore. Revenue grew 31% to ₹275 crore, while EBITDA margin expanded significantly to 13.1%.
29 Oct 2026
companies
Symphony Ltd reschedules Q2FY27 results call to 3 pm
Symphony Limited has revised the timing of its Q2FY27 results conference call. The session with Nirmal Bang Institutional Equities is now set for October 29, 2026, at 3:00 PM IST.
28 Oct 2026
companies
Symphony fixes Nov 4 record date for 2nd interim dividend
Symphony Limited has fixed November 4, 2026, as the record date for its second interim dividend for FY27, subject to board approval on October 29.
21 Oct 2026
companies
Symphony Ltd to meet Equirus Securities on Sep 29
Symphony Limited will hold a one-on-one meeting with Equirus Securities Private Limited on September 29, 2026, at its Ahmedabad registered office.
25 Sept 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo